Next, we examined the effect of RNase on the FcγRIIIA-stimulating activity of Ro60 mixed with serum IgG obtained from anti-Ro60 antibody–positive SLE or SS patients (Table 1). Here, FCGR3A is linked to synovial sarcoma.